Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
hepatitis b vaccine (recombinant) (Bio Farma)
- Development stage
- Approved
- Lead developer
- Serum Institute of India
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Administration
- Intramuscular
01
Overview
Recombinant hepatitis B vaccine is a non-infectious subunit viral vaccine containing the surface antigen (HBsAg) of the hepatitis B virus. It is produced using recombinant DNA technology, typically expressed in yeast (*Saccharomyces cerevisiae*). The vaccine works by inducing active immunity, stimulating the production of neutralizing antibodies against HBsAg to prevent infection by all known subtypes of the hepatitis B virus. PT Bio Farma, in collaboration with the Serum Institute of India (SII), has developed and tested specific formulations (using SII bulk) to ensure immunogenicity and safety in the Indonesian population. It is administered via intramuscular injection and is a cornerstone of global immunization programs for infants and high-risk adults.
- Brand names
- Hepatitis B (Bio Farma)
- Other names
- recombinant hepatitis B vaccineHepatitis B vaccine (rDNA)
02
Targets
HBsAg (Hepatitis B surface antigen)
Beyond the preview
Go deeper on hepatitis b vaccine (recombinant) (Bio Farma).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on hepatitis b vaccine (recombinant) (Bio Farma).